To diagnose heart conditions including heart attacks and heart rhythm disturbances, clinicians typically rely on 12-lead electrocardiograms (ECGs) -- complex arrangements of electrodes and wires ...

UK digital health company RHYTHM AI has claimed FDA approval for a new version of its algorithm for mapping areas of the heart that are affected by atrial fibrillation (AFib) that will be rolled out ...

conditions affecting the heart muscle (cardiomyopathies and myocarditis). Around 920,000 people in the UK were living with heart failure in 2018 with an estimated 200,000 new diagnoses each year.

SARASOTA, Fla.--(BUSINESS WIRE)--A newly published study in Heart Rhythm reveals how artificial intelligence (AI) algorithms embedded in Medtronic’s LINQ II implantable loop recorders (ILRs) ...

SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has ...

LA JOLLA, CA—To diagnose heart conditions including heart attacks and heart rhythm disturbances, clinicians typically rely on 12-lead electrocardiograms (ECGs)—complex arrangements of electrodes and ...

The HF-AI technology aligns perfectly with our mission to transform complex cardiac data into actionable insights that improve patient outcomes.” - Shawn Kumar, CEO of RhythmScienceSAN FRANCISCO, CA, ...

iRhythm Technologies (IRTC) presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific sessions. Large-scale analysis of more than ...

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...